Item 5.02: Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 24, 2020, the Board of Directors (the "Board") of Cardinal Health, Inc.
(the "Company") elected David C. Evans to the Board, effective July 1, 2020, to
serve until the 2020 annual meeting of shareholders and until his successor is
elected and qualified. Mr. Evans has previously served as Executive Vice
President and Chief Financial Officer of Battelle Memorial Institute, a private
research and development organization, from 2013 to 2018. Prior to that, he was
Executive Vice President and Chief Financial Officer of The Scotts Miracle-Gro
Company, the leading manufacturer and marketer of branded consumer lawn and
garden products in North America, from 2006 to 2013. Most recently, Mr. Evans
was interim Chief Financial Officer of the Company from September 1, 2019
through May 25, 2020 after a transition role beginning July 29, 2019.
Mr. Evans will participate in the non-management director compensation
arrangements described in the Company's definitive proxy statement for the 2019
annual meeting of shareholders filed with the Securities and Exchange Commission
on September 20, 2019. Based on his date of service, he will also receive a
prorated initial grant of $65,384 of restricted share units. The committee(s) of
the Board on which Mr. Evans initially will serve have not been determined as of
the time of this filing. After considering the fact that Mr. Evans had been
recruited and served in an interim executive officer position for less than a
year, and his fixed compensation arrangements, the Board determined that Mr.
Evans is independent under the standards of the New York Stock Exchange and the
Company's Corporate Governance Guidelines.
Item 7.01: Regulation FD Disclosure.
The Company issued a news release on June 26, 2020, announcing the election of
Mr. Evans to the Board, which is being furnished as Exhibit 99.1 to this Form
8-K.
Item 9.01: Financial Statements and Exhibits.
(d) Exhibits

Exhibit
 Number   Exhibit Description
            News release issued by the Company on June 26, 2020 and furnished with
   99.1   this Form 8-K
          The cover page from this Current Report on Form 8-K, formatted in Inline
    104   XBRL (included as Exhibit 101)

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------




                                   Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cardinal Health, Inc.
                      (Registrant)

Date: June 26, 2020 By: /s/ Jessica L. Mayer

Jessica L. Mayer
                          Chief Legal and Compliance Officer

© Edgar Online, source Glimpses